# OR5L2

## Overview
The OR5L2 gene encodes the protein olfactory receptor family 5 subfamily L member 2, which is a member of the G-protein-coupled receptor (GPCR) superfamily. This protein is primarily involved in the olfactory system, where it functions as a receptor for odorant molecules, contributing to the sense of smell through a 7-transmembrane domain structure that facilitates G-protein-mediated signal transduction (de2018Association). While OR5L2 is predominantly expressed in the olfactory epithelium, emerging research suggests that olfactory receptors, including OR5L2, may have roles beyond olfaction, potentially influencing physiological processes such as wound healing and myocardial function (Qu2020Weighted). Additionally, mutations in OR5L2 have been associated with cancer treatment resistance, highlighting its potential clinical significance in oncology (Bagaria2022Discriminating). Despite these findings, the full spectrum of OR5L2's functions and implications in non-olfactory tissues and disease contexts remains an active area of investigation.

## Function
The OR5L2 gene encodes an olfactory receptor protein that is part of the G-protein-coupled receptor (GPCR) family, which is the largest gene family in humans. These receptors are primarily involved in the detection of odorant molecules, initiating a neuronal response that leads to the perception of smell. OR5L2, like other olfactory receptors, shares a 7-transmembrane domain structure common to many neurotransmitter and hormone receptors, facilitating G-protein-mediated signal transduction (de2018Association).

In healthy human cells, OR5L2 is expressed in the olfactory epithelium, where it binds specific odorants. This binding triggers a signal transduction pathway that results in the perception of smell, contributing to the diversity of olfactory detection (de2018Association). Beyond its role in olfaction, olfactory receptors, including OR5L2, have been implicated in various physiological processes such as wound healing and myocardial function. Dysregulation of these receptors has been linked to cancer cell proliferation, apoptosis, and migration, suggesting potential roles beyond olfactory perception (Qu2020Weighted). However, specific functions of OR5L2 in non-olfactory tissues remain to be fully elucidated.

## Clinical Significance
The OR5L2 gene, part of the olfactory receptor family, has been studied in the context of cancer treatment responses. In a study on rectal cancer patients, mutations in OR5L2 were found exclusively in those who did not achieve a complete response to neoadjuvant chemotherapy. This suggests that OR5L2 mutations may be associated with treatment resistance, indicating potential clinical significance in understanding and predicting patient responses to chemotherapy (Bagaria2022Discriminating).

In ovarian cancer research, OR5L2 was included in a CRISPRi screen aimed at identifying genes that, when knocked down, increase sensitivity to platinum-based chemotherapeutics. However, the study did not provide specific information on the clinical significance of OR5L2 mutations or expression changes in this context (Handly2020Abstract).

In small-cell lung cancer, OR5L2 was mentioned as one of the genes with concurrent mutations alongside OX40, although the study did not elaborate on the clinical implications of OR5L2 in this setting (Chen2021Immune). Overall, while OR5L2 has been implicated in cancer-related studies, its specific clinical significance remains to be fully elucidated.


## References


[1. (Chen2021Immune) Peixin Chen, Hao Wang, Lishu Zhao, Haoyue Guo, Liping Zhang, Wei Zhang, Chenglong Sun, Sha Zhao, Wei Li, Jun Zhu, Jia Yu, Chunyan Wu, and Yayi He. Immune checkpoints ox40 and ox40l in small-cell lung cancer: predict prognosis and modulate immune microenvironment. Frontiers in Oncology, November 2021. URL: http://dx.doi.org/10.3389/fonc.2021.713853, doi:10.3389/fonc.2021.713853. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.713853)

[2. (de2018Association) Marcos Vinicius Antunes de Lemos, Elisa Peripolli, Mariana Piatto Berton, Fabiele Loise Braga Feitosa, Bianca Ferreira Olivieri, Nedenia Bonvino Stafuzza, Rafael Lara Tonussi, Sabrina Kluska, Hermenegildo Lucas Justino Chiaia, Lenise Mueller, Adrielli Mathias Ferrinho, Angelica Simone Cravo Prereira, Henrique Nunes de Oliveira, Lucia Galvão de Albuquerque, and Fernando Baldi. Association study between copy number variation and beef fatty acid profile of nellore cattle. Journal of Applied Genetics, 59(2):203–223, March 2018. URL: http://dx.doi.org/10.1007/s13353-018-0436-7, doi:10.1007/s13353-018-0436-7. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13353-018-0436-7)

[3. (Qu2020Weighted) Shuping Qu, Qiuyuan Shi, Jing Xu, Wanwan Yi, and Hengwei Fan. Weighted gene coexpression network analysis reveals the dynamic transcriptome regulation and prognostic biomarkers of hepatocellular carcinoma. Evolutionary Bioinformatics, January 2020. URL: http://dx.doi.org/10.1177/1176934320920562, doi:10.1177/1176934320920562. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1176934320920562)

[4. (Bagaria2022Discriminating) Jaya Bagaria, Kyung-Ok Kim, Eva Bagyinszky, Seong Soo A. An, and Jeong-Heum Baek. Discriminating potential genetic markers for complete response and non-complete response patients to neoadjuvant chemotherapy with locally advanced rectal cancer. International Journal of Environmental Research and Public Health, 19(7):4008, March 2022. URL: http://dx.doi.org/10.3390/ijerph19074008, doi:10.3390/ijerph19074008. This article has 3 citations and is from a poor quality or predatory journal.](https://doi.org/10.3390/ijerph19074008)

[5. (Handly2020Abstract) Erika D. Handly, Yi Wen Kong, Christian J. Braun, Jesse C. Patterson, and Michael B. Yaffe. Abstract a44: a crispri screen to identify combination therapies for improved treatment of ovarian cancer. Clinical Cancer Research, 26(13_Supplement):A44–A44, July 2020. URL: http://dx.doi.org/10.1158/1557-3265.ovca19-a44, doi:10.1158/1557-3265.ovca19-a44. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1557-3265.ovca19-a44)